Start your search now!
This map may not include all hospitals in your areas where MitraClip® therapy is available, but it is updated often. Sites listed here are not recommendations that certain hospitals or doctors are right for you. Abbott makes no guarantee as to any treatment outcome. Talk to your doctor about the best treatment option for you.
MitraClip® NT Clip Delivery System
INDICATION FOR USE
The MitraClip® NT Clip Delivery System is indicated for the percutaneous reduction of significant symptomatic mitral regurgitation (MR ≥ 3+) due to primary abnormality of the mitral apparatus [degenerative MR] in patients who have been determined to be at prohibitive risk for mitral valve surgery by a heart team, which includes a cardiac surgeon experienced in mitral valve surgery and a cardiologist experienced in mitral valve disease, and in whom existing comorbidities would not preclude the expected benefit from reduction of the mitral regurgitation.
Prior to use, please reference the Instructions for Use at www.abbottvascular.com/ifu for more information on indications, contraindications, warnings, precautions, and adverse events.
You are now leaving MitraClip.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click the appropriate button below.